Is IDEXX Laboratories (IDXX) Fairly Valued After Its 2025 Corporate Responsibility Report?
IDEXX Releases 2025 Corporate Responsibility Report Highlighting Innovation and Sustainability Progress
IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620
Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings
IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention
IDEXX Laboratories Earnings Preview: What to Expect
ALC vs. IDXX: Which Stock Is the Better Value Option?
IDEXX Laboratories to Release 2026 Second Quarter Financial Results
Is the Options Market Predicting a Spike in IDEXX Laboratories Stock?
A Small Upgrade Could Have a Big Impact for IDEXX Customers
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
Is IDEXX Laboratories Stock Underperforming the Nasdaq?
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference
IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.